首页|膀胱尿路上皮癌中IL9R表达及临床意义

膀胱尿路上皮癌中IL9R表达及临床意义

扫码查看
目的 检测IL9R在膀胱尿路上皮癌中的表达及其临床意义,并探讨其表达与免疫细胞浸润的关系.方法 采用GEPIA网站在线分析TCGA数据库中不同IL9R表达膀胱尿路上皮癌患者总生存期(OS)以及无病生存期(DFS).收集火箭军特色医学中心手术治疗的 118 例膀胱尿路上皮癌患者作为研究对象,15 例患者标本检测IL9R基因表达水平,其余103 例患者组织石蜡包埋后进行免疫组化染色检测IL9R蛋白表达.分析IL9R蛋白表达与患者临床病理特征的关系,采用Kaplan-Meier法绘制生存曲线分析,生存差异行Log-rank检验.Cox风险比例回归分析影响膀胱尿路上皮癌患者预后的因素.TIMER数据库分析膀胱尿路上皮癌患者IL9R表达与免疫细胞浸润的关系.结果 GEPIA网站在线分析显示肿瘤组织中IL9R低表达患者OS以及DFS均显著低于IL9R高表达患者.膀胱尿路上皮癌组织中IL9R基因表达水平显著低于癌旁组织(P<0.05);癌组织IL9R蛋白表达染色评分为 4.34±2.35,显著低于癌旁正常组织的 5.22±2.55,差异具有统计学意义(P<0.05).IL9R表达与性别、年龄、分化程度、T分期、N分期、M分期均无关(P>0.05);仅与TNM分期有关(P<0.05).单因素、多因素Cox风险比例回归模型分析结果显示,IL9R表达是影响术后膀胱尿路上皮癌患者OS的独立因素(P=0.03).TIMER数据库分析显示,IL9R表达水平与CD8+T细胞及M1 型巨噬细胞浸润程度呈现正相关.结论 IL9R在膀胱尿路上皮癌组织中表达下调,IL9R低表达提示预后较差,可能通过抑制CD8+T细胞和M1 型巨噬细胞的浸润影响预后.
Expression and clinical significance of IL9R in bladder urothelial carcinoma
Objective To investigate the expression and clinical significance of IL9R in bladder urothelial carcinoma,and to explore the relationship between IL9R expression and immune cell infiltration.Methods GEPIA website was used to analyze the overall survival(OS)and disease-free survival(DFS)of patients with different IL9R expression in the TCGA database.A total of 118 patients with bladder urothelial carcinoma treated by surgery in our hospital were collected as research objects.The expression level of IL9R gene was detected in samples of 15 patients,and the expression of IL9R protein was detected by immunohistochemical staining after paraffin embedding in tissues of 103 patients.The relationship between IL9R protein expression and clinicopathological features of patients was analyzed.Kaplan-Meier method was used to draw survival curves for analysis,and survival differences were tested by Log-rank.Cox proportional regression analysis of risk factors affecting the prognosis of patients with bladder urothelial carcinoma.The relationship between IL9R expression and immune cell infiltration in patients with bladder urothelial carcinoma was analyzed by TIMER database.Results GEPIA online analysis showed that the OS and DFS in patients with low expression of IL9R were significantly lower than those with high expression of IL9R.The expression level of IL9R gene in bladder urothelial carcinoma tissues was significantly lower than that in paracancer tissues(P<0.05).IL9R protein expression score in cancer tissues was 4.34±2.35,which was significantly lower than 5.22±2.55 in adjacent normal tissues,with statistical significance(P<0.05).The expression of IL9R was not correlated with sex,age,differentiation degree,T stage,N stage and M stage(P>0.05).Only the TNM stage was related(P<0.05).Univariate and multivariate Cox proportional regression analysis showed that IL9R expression was an independent factor affecting OS in patients with postoperative bladder urothelial carcinoma(P=0.03).The analysis of TIMER database showed that the expression level of IL9R was positively correlated with the infiltration degree of CD8+T cells and M1 macrophages.Conclusion The expression of IL9R is down-regulated in bladder urothelial carcinoma,and low expression of IL9R indicates poor prognosis,which may affect prognosis by inhibiting the infiltration of CD8+T cells and M1 macrophages.

Bladder Urothelial CarcinomaIL9RCD8+ T CellsMacrophagesPrognosis

孙家各、孙博、侯备、胡志元、叶学荣、张润泽、刘德忠、赵国华、张晓毅

展开 >

100088 北京 火箭军特色医学中心泌尿外科

膀胱尿路上皮癌 IL9R CD8+T细胞 巨噬细胞 预后

2024

临床肿瘤学杂志
解放军第八一医院

临床肿瘤学杂志

CSTPCD
影响因子:1.583
ISSN:1009-0460
年,卷(期):2024.29(3)
  • 14